Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

UKRI puts £162m into two institutes

1 min read
16:30UTC

UK Research and Innovation allocated £162 million on 14 September, £95 million to the Henry Royce Institute and £67.7 million to the Rosalind Franklin Institute.

TechnologyDeveloping
Key takeaway

Two shared-facility institutes take £162 million that small companies will use without owning.

UK Research and Innovation (UKRI), the national research funding body, allocated £162 million on 14 September, of which £95 million goes to the Henry Royce Institute for advanced materials and £67.7 million to the Rosalind Franklin Institute for life-sciences technology⁠1. Neither institute is a laboratory in one building. Both operate shared equipment and expertise that university groups and small companies book rather than buy, which is why an allocation to two named institutes reaches companies that will never appear on the award list. Capital equipment of this kind sets what a British spinout can attempt without raising the money to buy an instrument first. UKRI has been issuing awards through a period when its own sponsor department's name has not settled on gov.uk, and the allocations have gone out regardless.

Deep Analysis

In plain English

UK Research and Innovation (UKRI), the government body that funds scientific research, gave £162m to two national institutes. £95m went to the Henry Royce Institute, which researches new materials and is based in Manchester, and £67.7m went to the Rosalind Franklin Institute, which develops new technology for life sciences and is based at Harwell in Oxfordshire. Both institutes provide shared equipment and expertise that individual universities and companies could not afford alone, letting researchers across the country use advanced facilities through one national body rather than each building their own.

First Reported In

Update #15 · Nscale takes $103.4bn of contracts to NYSE

UK Research and Innovation· 21 Sept 2026
Read original →
Causes and effects
This Event
UKRI puts £162m into two institutes
Both institutes run shared facilities that spinouts and small companies use rather than build, so the money reaches further than the two recipients.
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.